Nektar Therapeutics
NASDAQ:NKTR 3:59:24 PM EDT
| Market Cap (Intraday) | 4.09B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $22.92 |
| 50-Day MA | $19.51 |
| 200-Day MA | $19.82 |
Nektar Therapeutics Stock, NASDAQ:NKTR
455 Mission Bay Boulevard South, San Francisco, California 94158
United States of America
Phone: +1.415.482.5300
Number of Employees: 723
Description
Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.